谷胱甘肽联合西地那非治疗勃起功能障碍患者临床疗效及对血管内皮功能的影响OACSTPCD
Effects of glutamine combined with sildenafil on vascular endothelial function and clinical efficacy in ED patients
目的 探究谷胱甘肽联合西地那非治疗勃起功能障碍(ED)患者临床疗效及对血管内皮功能、炎性因子、勃起功能的影响.方法 选取2022年10月—2023年10月新疆维吾尔自治区人民医院泌尿中心诊治ED患者89例作为研究对象,随机数字表法分为单药组44例和联合组45例.单药组给予西地那非口服治疗,联合组在单药组基础上给予还原型谷胱甘肽片口服治疗,2组患者均连续治疗1个月.观察2组患者治疗前、治疗结束时及治疗后1 个月的血管内皮功能(NO、ET、VEGF、ES)、炎性因子(hs-CRP、IL-6、IL-8、IL-10)、勃起功能(IIEF-5、QEQ、EHS、PSV)变化,比较2组临床疗效、不良事件发生率.结果 治疗结束后1个月,联合组临床治疗总有效率为91.11%,高于单药组的75.00%(x2/P=4.121/0.042);治疗结束时及治疗结束后1个月,联合组患者血清NO、VEGF水平显著高于单药组,ET水平显著低于单药组(治疗结束时:t/P=5.323/<0.001,3.808/<0.001,3.683/<0.001;治疗结束后1个月:t/P=2.615/0.011,3.197/0.002,3.089/0.003);血清 hs-CRP、IL-6 水平显著低于单药组(治疗结束时:t/P=8.323/<0.001,2.364/0.020;治疗结束后 1 个月:t/P=6.787/<0.001,2.662/0.009);IIEF-5、QEQ、EHS 及 PSV 均显著高于治疗前,其中EHS及PSV也显著高于单药组(治疗结束时:t/P=6.410/<0.001,4.066/<0.001;治疗结束后1个月:t/P=8.928/<0.001,4.532/<0.001);2组患者不良事件发生率比较差异无统计学意义(P>0.05).结论 谷胱甘肽联合西地那非能够有效改善ED患者血管内皮功能及勃起功能,同时显著降低患者炎性因子水平,且对于ED患者具有显著临床疗效及安全性.
Objective To explore the effects of glutathione combined with sildenafil on vascular endothelial func-tion,inflammatory response level,erectile function and clinical efficacy in patients with erectile dysfunction(ED).Methods Eighty-nine ED patients diagnosed and treated in the Urology Center of the People's Hospital of Xinjiang Uygur Autono-mous Region from October 2022 to October 2023 were selected as the study objects,and were randomly divided into mono-therapy group and combined treatment group,with 44 cases in the monotherapy group and 45 cases in the combined treat-ment group.The monotherapy group was given oral sildenafil treatment,and the combined treatment group was given oral treatment with reduced glutathione tablets.All patients were treated continuously for 1 month.The clinical efficacy,vascular endothelial function(NO,ET,VEGF,ES),inflammatory response level(hs-CRP,IL-6,IL-8,IL-10),erectile function(IIEF-5,QEQ,EHS,PSV)and incidence of adverse events were compared between the two groups before treatment,at the end of treatment and one month after treatment.Results One month after the end of treatment,the total effective rate of combined treatment group was 91.11%,which was higher than that of monotherapy group(75.00%,x2/P=4.121/0.042).At the end of treatment and 1 month after treatment,the mean serum levels of NO and VEGF in combined treatment group were signifi-cantly higher than those before treatment and monotherapy group,and the mean ET levels were significantly lower than those before treatment and monotherapy group(t/P=5.323/<0.001,3.683/<0.001,3.808/<0.001,2.615/0.011,3.089/0.003,3.197/0.002).Average serum hs-CRP and IL-6 levels were significantly lower than those before treatment and in monotherapy group(t/P=8.323/<0.001,2.364/0.020,6.787/<0.001,2.662/0.009).Average IIEF-5,QEQ,EHS and PSV were significantly higher than before treatment,and EHS and PSV were also significantly higher than monotherapy group(t/P=6.410/<0.001,4.066/<0.001,8.928/<0.001,4.532/<0.001).There was no significant difference in cure rate and incidence of adverse events between the two groups(P>0.05).Conclusion Glutathione combined with sildenafil can effectively improve vascular en-dothelial function and erectile function in ED patients,and significantly reduce the level of inflammation.The combine treat-ment scheme has remarkable clinical efficacy and safety for ED patients,and has wide clinical application prospect.
南玉奎;姚礼忠;阿不都热合曼·帕塔尔;贾宏亮;李九智
830001 乌鲁木齐,新疆维吾尔自治区人民医院泌尿中心
临床医学
勃起功能障碍西地那非谷胱甘肽血管内皮功能炎性因子疗效
Erectile dysfunctionSildenafilGlutathioneVascular endothelial functionInflammatory factorThera-peutic effect
《疑难病杂志》 2024 (007)
856-860,865 / 6
新疆维吾尔自治区自然科学基金项目(2022D01C613) Natural Science Foundation in Xinjiang Uygur Autonomous Region(2022D01C613)
评论